Theoretical Schemas to Guide Back Pain Consortium (BACPAC) Chronic Low Back Pain Clinical Research.
Journal Information
Full Title: Pain Med
Abbreviation: Pain Med
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Psychophysiology
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"the keywords and medical subject headings were selected to capture diverse but relevant systematic reviews and meta-analyses ( supplementary data 1 ).; to enable application to the final set of reviews minor modifications were made to the amstar 2 template ( supplementary data 2 ).; across the 45 studies the study authors individually presented conclusions on soe for 89 rpf-outcome associations ( supplementary data 3 )."
"Conflicts of interest: Anthony Chiu, Sharis Steib, Evans Whitaer, David Kohns, Alexader Quinter, Anita Craig, Anthony Chiodo, SriKrishan Chandran, Ann Laidlaw, Zachary Schott, Nathan Farlow, John Yarjanian, Ashley Omwanghe, Ronald Wasserman, Anton Bowden, William Marras, Tim Carey, Wolf Mehling, Anthony Hunt declare no conflict of interest for this work. Jeffrey Lotz has royalties/licenses with Aclarion, royalties/licenses/consulting fees with Relievant MedSystems, and stock/stock options with Relievant MedSystems, Aclarion, and Bioniks, and is the Secretary of the International Society for the Study of the Lumbar Spine ISSLS (no payments). Dan Clauw performs consulting and receives consulting fees from Pfizer, Lilly, Tonix, Virias, IMC, Lundbeck, Teva, Aptinyx, and Sammumed. He also received payments for an expert testimony against opioid manufacturers in Oklahoma and Florida. Conor O'Neill has stock/stock options with and Aclarion."
"Funding This article was developed as part of the National Institutes of Health (NIH) Back Pain Consortium (BACPAC) Research Program that was funded as part of the NIH Helping to End Addiction Long-term Initiative (HEAL Initiative) (U19AR076737). Conflicts of interest: Anthony Chiu, Sharis Steib, Evans Whitaer, David Kohns, Alexader Quinter, Anita Craig, Anthony Chiodo, SriKrishan Chandran, Ann Laidlaw, Zachary Schott, Nathan Farlow, John Yarjanian, Ashley Omwanghe, Ronald Wasserman, Anton Bowden, William Marras, Tim Carey, Wolf Mehling, Anthony Hunt declare no conflict of interest for this work. Jeffrey Lotz has royalties/licenses with Aclarion, royalties/licenses/consulting fees with Relievant MedSystems, and stock/stock options with Relievant MedSystems, Aclarion, and Bioniks, and is the Secretary of the International Society for the Study of the Lumbar Spine ISSLS (no payments). Dan Clauw performs consulting and receives consulting fees from Pfizer, Lilly, Tonix, Virias, IMC, Lundbeck, Teva, Aptinyx, and Sammumed. He also received payments for an expert testimony against opioid manufacturers in Oklahoma and Florida. Conor O'Neill has stock/stock options with and Aclarion. Authorship has been granted only to those individuals who have contributed substantively to the work presented in this article. Study registration: Open Science Framework (Center of Open Science; https://osf.io/8ajvf)."
"Funding: This article was developed as part of the National Institutes of Health (NIH) Back Pain Consortium (BACPAC) Research Program that was funded as part of the NIH Helping to End Addiction Long-term Initiative (HEAL Initiative) (U19AR076737).: Conflicts of interest: Anthony Chiu, Sharis Steib, Evans Whitaer, David Kohns, Alexader Quinter, Anita Craig, Anthony Chiodo, SriKrishan Chandran, Ann Laidlaw, Zachary Schott, Nathan Farlow, John Yarjanian, Ashley Omwanghe, Ronald Wasserman, Anton Bowden, William Marras, Tim Carey, Wolf Mehling, Anthony Hunt declare no conflict of interest for this work. Jeffrey Lotz has royalties/licenses with Aclarion, royalties/licenses/consulting fees with Relievant MedSystems, and stock/stock options with Relievant MedSystems, Aclarion, and Bioniks, and is the Secretary of the International Society for the Study of the Lumbar Spine ISSLS (no payments). Dan Clauw performs consulting and receives consulting fees from Pfizer, Lilly, Tonix, Virias, IMC, Lundbeck, Teva, Aptinyx, and Sammumed. He also received payments for an expert testimony against opioid manufacturers in Oklahoma and Florida. Conor O'Neill has stock/stock options with and Aclarion.: Authorship has been granted only to those individuals who have contributed substantively to the work presented in this article.: Study registration: Open Science Framework (Center of Open Science; https://osf.io/8ajvf)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025